1. Ford E, Nelson KE, Warren D. Epidemiology of epidemic keratoconjunctivitis. Epidemiol Rev 1987;9:244-261.
3. Sundmacher R, Hillenkamp J, Reinhard T. Prospects for therapy and prevention of adenovirus keratoconjunctivitis. Ophthalmologe 2001;98:991-1007.
4. Sambursky RP, Fram N, Cohen EJ. The prevalence of adenoviral conjunctivitis at the Wills Eye Hospital Emergency Room. Optometry 2007;78:236-239.
5. Aoki K, Tagawa Y. A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan. Int Ophthalmol Clin 2002;42:49-54.
6. Keenlyside RA, Hierholzer JC, D'Angelo LJ. Keratoconjunctivitis associated with adenovirus type 37: an extended outbreak in an ophthalmologist's office. J Infect Dis 1983;147:191-198.
7. Gordon YJ, Gordon RY, Romanowski E, Araullo-Cruz TP. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology 1993;100:1835-1839.
8. Mema SC, MacDonald J, Wyse JP, Gonder T, Musto R, McIntyre L. Public health adds value to an investigation of epidemic keratoconjunctivitis. Can J Ophthalmol 2010;45:538.
9. Azar MJ, Dhaliwal DK, Bower KS, Kowalski RP, Gordon YJ. Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis. Am J Ophthalmol 1996;121:711-712.
10. Guyer B, O'Day DM, Hierholzer JC, Schaffner W. Epidemic keratoconjunctivitis: a community outbreak of mixed adenovirus type 8 and type 19 infection. J Infect Dis 1975;132:142-150.
11. Rowe WP, Huebner RJ, Gilmore LK, Parrott RH, Ward TG. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 1953;84:570-573.
12. Jawetz E, Kimura S, Nicholas AN, Thygeson P, Hanna L. New type of APC virus from epidemic keratoconjunctivitis. Science 1955;122:1190-1191.
14. Martone WJ, Hierholzer JC, Keenlyside RA, Fraser DW, D'Angelo LJ, Winkler WG. An outbreak of adenovirus type 3 disease at a private recreation center swimming pool. Am J Epidemiol 1980;111:229-237.
15. D'Angelo LJ, Hierholzer JC, Keenlyside RA, Anderson LJ, Martone WJ. Pharyngoconjunctival fever caused by adenovirus type 4: report of a swimming pool-related outbreak with recovery of virus from pool water. J Infect Dis 1979;140:42-47.
16. Tabbara KF, Omar N, Hammouda E, Akanuma M, Ohguchi T, Ariga T, Tagawa Y, Kitaichi N, Ishida S, Aoki K, Ishiko H, Ohno S. Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi Arabia. Mol Vis 2010;16:2132-2136.
18. Laibson PR. Ocular adenoviral infections. Int Ophthalmol Clin 1984;24:49-64.
19. Yamazaki ES, Ferraz CA, Hazarbassanov RM, Allemann N, Campos M. Phototherapeutic keratectomy for the treatment of corneal opacities after epidemic keratoconjunctivitis. Am J Ophthalmol 2011;151:35-43.
20. Kuo SC, Shen SC, Chang SW, Huang SC, Hsiao CH. Corneal superinfection in acute viral conjunctivitis in young children. J Pediatr Ophthalmol Strabismus 2008;45:374-376.
21. Oh JY, Shin YJ, Wee WR. A case of epidemic keratoconjunctivitis complicated by Alcaligenes xylosoxidans infection. Korean J Ophthalmol 2005;19:233-234.
22. Siamak NM, Kowalski RP, Thompson PP, Romanowski EG, Shanks RM, Gordon YJ. RPS adeno detector. Ophthalmology 2009;116:591-591.e1.
24. Sambursky R, Tauber S, Schirra F, Kozich K, Davidson R, Cohen EJ. The RPS adeno detector for diagnosing adenoviral conjunctivitis. Ophthalmology 2006;113:1758-1764.
25. Romanowski EG, Roba LA, Wiley L, Araullo-Cruz T, Gordon YJ. The effects of corticosteroids of adenoviral replication. Arch Ophthalmol 1996;114:581-585.
26. Romanowski EG, Yates KA, Gordon YJ. Short-term treatment with a potent topical corticosteroid of an acute ocular adenoviral infection in the New Zealand white rabbit. Cornea 2001;20:657-660.
27. Trousdale MD, Barlow WE, McGuigan LJ. Assessment of diclofenac on herpes keratitis in rabbit eyes. Arch Ophthalmol 1989;107:1664-1666.
28. Vajpayee RB, Sharma N, Chand M, Tabin GC, Vajpayee M, Anand JR. Corneal superinfection in acute hemorrhagic conjunctivitis. Cornea 1998;17:614-617.
29. Laibson PR, Dhiri S, Oconer J, Ortolan G. Corneal infiltrates in epidemic keratoconjunctivitis: response to double-blind corticosteroid therapy. Arch Ophthalmol 1970;84:36-40.
30. Hillenkamp J, Reinhard T, Ross RS, Bohringer D, Cartsburg O, Roggendorf M, De Clercq E, Godehardt E, Sundmacher R. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology 2002;109:845-850.
32. Levinger E, Slomovic A, Sansanayudh W, Bahar I, Slomovic AR. Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. Cornea 2010;29:638-640.
33. Reinhard T, Sundmacher R. Local cyclosporin A therapy of nummuli after epidemic keratoconjunctivitis: case report. Klin Monbl Augenheilkd 1997;210:165-168.
34. Kovalyuk N, Kaiserman I, Mimouni M, Cohen O, Levartovsky S, Sherbany H, Mandelboim M. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol 2017;03. 25. [Epub]. 10.1111/aos.13416.
36. Uchio E. New medical treatment for viral conjunctivitis. Nippon Ganka Gakkai Zasshi 2005;109:962-984.
37. Teuchner B, Nagl M, Schidlbauer A, Ishiko H, Dragosits E, Ulmer H, Aoki K, Ohno S, Mizuki N, Gottardi W, Larcher C. Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis: a double-blind, randomized, phase-2 clinical trial. J Ocul Pharmacol Ther 2005;21:157-165.
38. Romanowski EG, Yates KA, Gordon YJ. The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections. Invest Ophthalmol Vis Sci 2009;50:5295-5299.
39. Chaberny IE, Schnitzler P, Geiss HK, Wendt C. An outbreak of epidemic keratoconjunctivtis in a pediatric unit due to adenovirus type 8. Infect Control Hosp Epidemiol 2003;24:514-519.